PHASTAR announces appointment of Managing Director
PHASTAR a specialist Contract Research Organization offering statistical consultancy, clinical trial reporting and data management services with offices in the UK, USA, Kenya, and Australia, announces the appointment of Andrew MacGarvey to the Managing Director role.
PHASTAR announced the appointment of Andrew MacGarvey today. He will take on the Managing Director role and will be based in London. “I am delighted to be joining PHASTAR at a very exciting time for the business. The company has over 200 colleagues across four continents and continues to grow to meet increasing demand. I am looking forward to contributing to the continued success of the business and meeting our teams and customers across the globe.”
Andrew has twenty years’ experience in the clinical development environment having served in a variety of Contract Research Organizations in both operational and commercial roles.
Kevin Kane, CEO and Founder of PHASTAR said, “Andrew is an important addition to our team; I am very much looking forward to working with him. He will manage the next stage of the company’s growth bringing with him invaluable experience of scaling businesses. His focus on excellent customer service fits perfectly with our emphasis on high-quality deliverables.”
PHASTAR is a specialist contract research organisation (CRO) offering statistical consultancy, clinical trial reporting and medical writing services to the pharmaceutical, biotechnology, and medical device industries.
Services include production of clinical study reports, including generating tables, figures and listings; study design and protocol writing; modelling and simulation; and analysis of data across phase I to IV trials.
The company operates from headquarters is in Chiswick, London (UK), with three additional regional offices across the UK as well as the US-based PHASTAR Inc. located in Research Triangle Park, North Carolina (USA), and offices in Kenya and Australia.